Cannabis for Neuropathic Pain

Neuropathic pain — from nerve damage — is notoriously treatment-resistant. Cannabis achieves Grade A evidence for neuropathic pain in multiple systematic reviews, making it one of the best-supported non-opioid options for this challenging condition.

Grade A
Evidence Level
30-50%
Pain Reduction
3.5
NNT
Cannabis for Neuropathic Pain

Why Cannabis Works for Nerve Pain

Neuropathic pain involves abnormal electrical signaling in damaged nerves. The endocannabinoid system modulates pain signaling at multiple levels: peripheral sensitization, spinal processing, and cortical pain interpretation. THC activates CB1 receptors that inhibit TRPV1 channels — the primary mediators of neuropathic pain signals. CBD inhibits adenosine reuptake (anti-inflammatory) and acts directly on glycine receptors in the spinal cord to suppress central sensitization. Both cannabinoids reduce the "wind-up" phenomenon where nerve pain amplifies over time.

Evidence by Neuropathy Type

Cannabis evidence is strongest for HIV-associated neuropathy (multiple RCTs), diabetic peripheral neuropathy, MS-related neuropathic pain, and chemotherapy-induced neuropathy. A 2018 Cochrane review concluded cannabis-based medicines produce 30% or greater pain reduction in 38% of patients versus 21% placebo — a meaningful therapeutic effect. MS-related neuropathic pain responds particularly well to the approved Sativex formula (1:1 THC:CBD). Cancer neuropathy is addressed in the chemotherapy-induced peripheral neuropathy literature.

Best Cannabis Forms for Nerve Pain

Inhaled cannabis provides the fastest neuropathic pain relief but shortest duration. Sublingual tinctures (1:1 CBD:THC ratio) provide sustained nerve pain coverage for 3-5 hours. Full-extract cannabis oil is preferred over isolates for the entourage effect relevant to neuropathic pain. Topical cannabis helps for localized neuropathy (diabetic foot pain, post-herpetic neuralgia) with minimal systemic effects. For chemotherapy neuropathy, oral delivery is preferred to avoid inhalation complications.

Neuropathic Pain Management Strategy

Combine cannabis with established neuropathic pain medications rather than replacing them entirely. Cannabis works synergistically with gabapentinoids (gabapentin, pregabalin) and may allow dose reduction of these drugs. Keep pain diaries using validated scales (NRS, NPSI) to track cannabis efficacy. Neuropathic pain often responds to chronic daily dosing rather than as-needed use — consistent endocannabinoid system supplementation over weeks produces better outcomes than sporadic use. Most states with medical cannabis programs include neuropathy or chronic pain as qualifying conditions.

Trusted Sources

Frequently Asked Questions

Cannabis achieves Grade A evidence (highest level) for neuropathic pain. Approximately 38% of patients achieve 30% or greater pain reduction — comparable to gabapentin and significantly better than placebo in Cochrane meta-analysis.
Both work through different mechanisms. THC is more directly analgesic for acute nerve pain. CBD reduces central sensitization and neuroinflammation. The 1:1 combination (like Sativex) shows the best clinical evidence for neuropathic pain.
Yes — multiple randomized controlled trials show cannabis reduces diabetic peripheral neuropathy pain by 30-50%. Both inhaled and topical cannabis show efficacy for the burning, tingling foot pain of diabetic neuropathy.
Cannabis can complement gabapentin but should not replace it without medical guidance. Some patients achieve equivalent pain control with cannabis; others use it to reduce gabapentin doses and side effects. Never abruptly discontinue gabapentin.
A 1:1 THC:CBD ratio has the most clinical evidence for neuropathic pain. For daytime use with minimal impairment, higher CBD ratios (4:1 or greater) provide pain relief with less psychoactive effect.

Related Guides